ArticleDevelopmental biology2026
Fibulin-1 is required for microvascular integrity in the developing brain and retina.
Article in Developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Vascularization of the central nervous system and the postnatal retina proceeds through angiogenic growth that relies in part on the basement membrane (BM) to support endothelial cell-cell interactions and maintain barrier integrity during vessel formation. In addition to the core structural components of the BM, matricellular proteins are present as minor constituents, however, their contributions to endothelial cohesion and barrier stability during angiogenesis remain poorly defined. Here, we identify the matricellular protein Fibulin-1 (Fbln1), a regulator of cell-matrix interactions, as an essential factor during mid-gestation that prevents the formation of dilated, tortuous capillaries that give rise to glomeruloid vascular lesions and intracerebral hemorrhage. Fbln1-deficient brains exhibit vascular malformations characterized by reduced type IV collagen deposition and diminished CD31 localization at endothelial junctions. Although overall pericyte coverage across the vasculature is maintained, the glomeruloid lesions lack pericyte investment. In the developing retina, loss of Fbln1 similarly results in hemorrhage and tortuous capillaries with glomeruloid vascular abnormalities that disrupt the formation of both the superficial and deep vascular plexuses. Together, these findings demonstrate that Fbln1 is a critical determinant of brain and retinal vascular development and is required to preserve endothelial barrier integrity during angiogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.